PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3β-N-nsp3 cascade

PACT 通过阻断 GSK-3β-N-nsp3 级联抑制 SARS-CoV-2 的复制

阅读:10
作者:Ying-Ying Lin, Roubin Yao, Jiaxin Zhuang, Bo Wang, Liubing Du, Deyin Guo, Ji-An Pan, Xiaoxue Peng

Abstract

The protein activator of protein kinase R (PKR) (PACT) has been shown to play a crucial role in stimulating the host antiviral response through the activation of PKR, retinoic acid-inducible gene I, and melanoma differentiation-associated protein 5. Whether PACT can inhibit viral replication independent of known mechanisms is still unrevealed. In this study, we show that, like many viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hijacks GSK-3β to facilitate its replication. GSK-3β-induced phosphorylation on N protein increased the interaction between N protein and nsp3. Thus, GSK-3β-N-nsp3 cascade promotes viral replication. Although SARS-CoV-2 can sabotage the activation of AKT, the upstream proteins suppressing the activation of GSK-3β, we found that the host can use PACT, another protein kinase, instead of AKT to decrease the activity of GSK-3β and the interaction between PACT and GSK-3β is enhanced upon viral infection. Moreover, PACT inhibited the activity of GSK-3β independent of its well-studied double-stranded RNA binding and PKR activating ability. In summary, this study identified an unknown function of PACT in inhibiting SARS-CoV-2 replication through the blockage of GSK-3β-N-nsp3 cascade.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。